2022 Annual Meeting | S1 - Sleep: Want to Hear the Latest?
Program Materials Program Evaluations
01:00 PM - 01:24 PM PDT | Speaker |
2022 Sleep Science Award: This award recognizes distinguished academic contributions by neurologists to the field of sleep medicine or the contributions of non-neurologists to the interface area of sleep neurology.
Louis J. Ptacek, MD |
01:00 PM - 01:00 PM PDT | Speaker |
walk in slides
J. Kent Werner, Jr., MD, PhD |
01:24 PM - 01:36 PM PDT | Speaker |
2022 Wayne A. Hening Sleep Medicine Investigator Award: This award recognizes scientific contributions in sleep from promising young investigators.
J. Kent Werner, Jr., MD, PhD |
01:36 PM - 01:48 PM PDT | Abstract |
004 - Longitudinal 123I-FP-CIT SPECT Imaging in Isolated REM Sleep Behavior Disorder
Toji Miyagawa, MD, PhD |
01:48 PM - 02:00 PM PDT | Abstract |
005 - Poor sleep quality is associated with elevated exosomal inflammatory cytokines in warfighters with chronic mild TBI
Bryson Hewins |
02:00 PM - 02:12 PM PDT | Abstract |
006 - Acute blood biomarkers predict chronic insomnia trajectories following traumatic brain injury: A TRACK-TBI study
J. Kent Werner, Jr., MD, PhD |
02:12 PM - 02:24 PM PDT | Abstract |
007 - Impairment in Functioning and Quality of Life in Patients With Idiopathic Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study (ARISE)
Logan D. Schneider, MD |
02:24 PM - 02:36 PM PDT | Abstract |
008 - Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study
Rami Ben-Joseph, PhD |
02:36 PM - 02:48 PM PDT | Abstract |
009 - Safety and pharmacodynamics of a single infusion of TAK-925 in adults with idiopathic hypersomnia
Emmanuel Mignot, MD, PhD |
02:48 PM - 03:00 PM PDT | Abstract |
010 - Good Night, Sleep Tight, Don’t Let the Sleep Disturbances Bite
Alexander Poulakis |
Helene A. Emsellem, MD | The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Consulting. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel . The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips Respironics. The institution of Dr. Emsellem has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NLS Pharma. The institution of Dr. Emsellem has received research support from ApniMed. The institution of Dr. Emsellem has received research support from Axsome. The institution of Dr. Emsellem has received research support from Balance. The institution of Dr. Emsellem has received research support from Expansion. The institution of Dr. Emsellem has received research support from Avadel (Flamel). The institution of Dr. Emsellem has received research support from Harmony. The institution of Dr. Emsellem has received research support from Idorsia. The institution of Dr. Emsellem has received research support from Imbrium. The institution of Dr. Emsellem has received research support from Jazz. The institution of Dr. Emsellem has received research support from Merck. The institution of Dr. Emsellem has received research support from NLS. The institution of Dr. Emsellem has received research support from Philips. The institution of Dr. Emsellem has received research support from Suven. The institution of Dr. Emsellem has received research support from Takeda. The institution of Dr. Emsellem has received research support from Vanda. |
Kimbra L. Kenney, MD, FAAN | Dr. Kenney has nothing to disclose. |
David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
Michael Silber, MB, ChB, FAAN | Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate. |
Todd J. Swick, MD, FAAN | Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has stock in Takeda Pharmaceuticals. |
Phyllis C. Zee, MD, PhD | Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care. |
Louis J. Ptacek, MD | Dr. Ptacek has nothing to disclose. |
Ramon R. Diaz-Arrastia, MD, PhD, FAAN | Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
Nancy R. Foldvary-Schaefer, DO, FAAN | Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. |
Aatif M. Husain, MD | Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving as a Consultant for PranaQ. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Pharmaceuticals. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Husain has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UniQure. Dr. Husain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceutical. Dr. Husain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Federation of Clinical Neurophysiology. The institution of Dr. Husain has received research support from Marinus Pharmaecuticals. The institution of Dr. Husain has received research support from PranaQ. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has received publishing royalties from a publication relating to health care. Dr. Husain has a non-compensated relationship as a Vice Chair of CNP MOC committee with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities. |
Bradley F. Boeve, MD, FAAN | Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. |
Erik K. St. Louis, MD | The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. |
Emmanuel Mignot, MD, PhD | Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa . |
Flavia B. Consens, MD | Dr. Consens has nothing to disclose. |
Tanis J. Ferman, PhD | Ms. Ferman has nothing to disclose. |
Joseph T. Giacino, PhD | The institution of Dr. Giacino has received research support from National Institute on Disability, Independent Living and Rehabilitation Research. The institution of Dr. Giacino has received research support from National Institute on Neurological Disorders and Stroke. The institution of Dr. Giacino has received research support from Department of Defense. The institution of Dr. Giacino has received research support from SameYou Foundation. Dr. Giacino has received intellectual property interests from a discovery or technology relating to health care. |
Geoffrey Manley, MD, PhD | The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board. |
Kejal Kantarci, MD | The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. |
Richard K. Bogan, MD | Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Noctrix. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. The institution of Dr. Bogan has received research support from ZIO. The institution of Dr. Bogan has received research support from NLS. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. |
Val J. Lowe, MD | Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals. |
Joyce K. Lee-Iannotti, MD, FAAN | Dr. Lee-Iannotti has nothing to disclose. |
Rodolfo Savica, MD, PhD, FAAN | The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc. |
Raquel Gardner, MD | Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD. |
David T. Jones, MD | Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
Jonathan Graff-Radford, MD, FAAN | Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. |
Logan D. Schneider, MD | Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care. |
Laura Allen, NP | Ms. Allen has nothing to disclose. |
No disclosure on file | |
Melissa Naylor | Ms. Naylor has received personal compensation for serving as an employee of Takeda. Ms. Naylor has stock in Takeda. |
Jed Black, MD | Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in . |
Hugo Botha, MD | Dr. Botha has received research support from NIH. |
Stuart McCarter, MD | Dr. McCarter has received research support from NIH. |
J. Kent Werner, Jr., MD, PhD | Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics. |
Vijay K. Ramanan, MD, PhD | The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. The institution of Dr. Ramanan has received research support from Expert Perspectives in Medicine. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI. |
Michael Ibarra, MD | Dr. Ibarra has nothing to disclose. |
Julie A. Fields, PhD | The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute. |
Toji Miyagawa, MD, PhD | Dr. Miyagawa has nothing to disclose. |
Tina Olsson, PhD | Dr. Olsson has received personal compensation for serving as an employee of Takeda. Dr. Olsson has stock in Takeda. |
Leah K. Forsberg, PhD | Ms. Forsberg has nothing to disclose. |
Josephine Pierce Pucci, MD | Ms. Pucci has a non-compensated relationship as a co-founder with Headway Foundation that is relevant to AAN interests or activities. |
Jennifer Lin, MD | Ms. Lin has nothing to disclose. |
Rami Ben-Joseph, PhD | Dr. Ben-Joseph has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Ben-Joseph has stock in Jazz Pharmaceuticals. |
Wayne Macfadden, MD, PT | Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma. |
Douglas S. Fuller | Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals. |
Alexander Poulakis | Mr. Poulakis has nothing to disclose. |
Bryson Hewins | Mr. Hewins has nothing to disclose. |
Timothy Lesnick | No disclosure on file |
Virend Somers | Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Virend Somers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axome. Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ApniMed. The institution of Virend Somers has received research support from National Institutes Health. |
Scott Przybelski | Scott Przybelski has nothing to disclose. |
Walter Kremers | The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH. |
Ragy Saad | No disclosure on file |
Andrew Krystal | No disclosure on file |